Tue, November 8, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

David Amsellem Upgraded (VTRS) to Hold and Held Target at $10 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Tyler Batory Maintained (VVI) at Buy with Decreased Target to $42 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Toni Kaplan Initiated (VRSK) at Hold and Held Target at $170 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Nik Cremo Maintained (VRRM) at Buy with Decreased Target to $18 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Landon Park Maintained (VSAT) at Hold with Increased Target to $36 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Anthony Pettinari Maintained (SUM) at Strong Buy with Increased Target to $32 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Jason English Maintained (WW) at Hold with Decreased Target to $3.8 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Gregory Renza Maintained (XNCR) at Buy with Decreased Target to $36 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

David Anderson Maintained (XPRO) at Hold with Increased Target to $16 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Philip Cusick Upgraded (TDS) to Hold and Decreased Target to $14 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Phil Winslow Maintained (TDC) at Sell with Decreased Target to $30 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Matthew Hedberg Maintained (TDC) at Hold with Decreased Target to $37 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Douglas Tsao Maintained (TBPH) at Strong Buy with Increased Target to $19 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Richard Law Maintained (BEAM) at Hold with Decreased Target to $53 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Kieran De Brun Maintained (CE) at Hold with Decreased Target to $108 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Arun Viswanathan Maintained (CE) at Hold with Decreased Target to $98 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Andrew Cooper Maintained (CDNA) at Strong Buy with Decreased Target to $26 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Sami Badri Maintained (CCOI) at Hold with Increased Target to $57 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Derek Archila Maintained (CCCC) at Hold with Decreased Target to $11 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Lauren Lieberman Maintained (CCEP) at Buy with Decreased Target to $61 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

James Ricchiuti Maintained (CECO) at Strong Buy with Increased Target to $14 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Brian Drab Upgraded (SSYS) to Hold on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Nat Schindler Downgraded (SST) to Sell and Decreased Target to $4 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

George Tong Maintained (STER) at Strong Buy with Decreased Target to $21 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Lee Simpson Initiated (STM) at Hold on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Paul Golding Upgraded (SQ) to Buy and Held Target at $100 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Gregg Moskowitz Maintained (SNOW) at Strong Buy with Decreased Target to $185 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Gaurav Jain Upgraded (SMG) to Buy and Held Target at $75 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Jed Kelly Maintained (TREE) at Buy with Decreased Target to $35 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Chris Shibutani Maintained (TRDA) at Hold with Increased Target to $18 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Whitney Ijem Initiated (TNYA) at Strong Buy and Held Target at $21 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Whitney Ijem Initiated (TSHA) at Strong Buy and Held Target at $16 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Gabriel Moreen Maintained (TRGP) at Strong Buy with Increased Target to $92 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Mario Lu Maintained (TTWO) at Buy and Held Target at $130 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Eric Handler Maintained (TTWO) at Strong Buy with Decreased Target to $140 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Clay Griffin Maintained (TTWO) at Hold with Decreased Target to $115 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

David Karnovsky Maintained (TTWO) at Buy with Decreased Target to $144 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Omar Dessouky Upgraded (TTWO) to Strong Buy on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Doug Creutz Maintained (TTWO) at Buy with Decreased Target to $147 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Drew Crum Maintained (TTWO) at Strong Buy with Decreased Target to $130 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Matthew Cost Maintained (TTWO) at Buy with Decreased Target to $150 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Mike Hickey Maintained (TTWO) at Strong Buy with Decreased Target to $139 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Brian Fitzgerald Maintained (TTWO) at Buy with Decreased Target to $132 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Stephen Ju Maintained (TTWO) at Hold with Decreased Target to $122 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Matthew Harrison Maintained (TSVT) at Buy with Increased Target to $29 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Daina Graybosch Maintained (TSVT) at Buy with Decreased Target to $41 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Heiko Ihle Maintained (UUUU) at Strong Buy with Decreased Target to $9.5 on, Nov 8th, 2022

[ Tue, Nov 08th 2022 ]: WOPRAI

Philip Cusick Upgraded (USM) to Hold and Decreased Target to $24 on, Nov 8th, 2022

Douglas Tsao Maintained (TBPH) at Strong Buy with Increased Target to $19 on, Nov 8th, 2022

Douglas Tsao of HC Wainwright & Co., Maintained "Theravance Biopharma, Inc." (TBPH) at Strong Buy with Increased Target from $12 to $19 on, Nov 8th, 2022.

Douglas has made no other calls on TBPH in the last 4 months.



There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with Douglas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Douglas

  • Vikram Purohit of "Morgan Stanley" Maintained at Sell with Decreased Target to $10 on, Monday, July 25th, 2022